Literature DB >> 27481051

Structural mutation analysis of PTEN and its genotype-phenotype correlations in endometriosis and cancer.

Iris N Smith1, James M Briggs2.   

Abstract

The phosphatase and tensin homolog deleted on chromosome ten (PTEN) gene encodes a tumor suppressor phosphatase that has recently been found to be frequently mutated in patients with endometriosis, endometrial cancer and ovarian cancer. Here, we present the first computational analysis of 13 somatic missense PTEN mutations associated with these phenotypes. We found that a majority of the mutations are associated in conserved positions within the active site and are clustered within the signature motif, which contain residues that play a crucial role in loop conformation and are essential for catalysis. In silico analyses were utilized to identify the putative effects of these mutations. In addition, coarse-grained models of both wild-type (WT) PTEN and mutants were constructed using elastic network models to explore the interplay of the structural and global dynamic effects that the mutations have on the relationship between genotype and phenotype. The effects of the mutations reveal that the local structure and interactions affect polarity, protein structure stability, electrostatic surface potential, and global dynamics of the protein. Our results offer new insight into the role in which PTEN missense mutations contribute to the molecular mechanism and genotypic-phenotypic correlation of endometriosis, endometrial cancer, and ovarian cancer. Proteins 2016; 84:1625-1643.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  PTEN; anisotropic network model; endometrial cancer; endometriosis; genotype-phenotype; global dynamics; mutation; ovarian cancer; protein structure stability

Mesh:

Substances:

Year:  2016        PMID: 27481051      PMCID: PMC5073044          DOI: 10.1002/prot.25105

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  97 in total

1.  Nuclear PTEN: a tale of many tails.

Authors:  A Gil; A Andrés-Pons; R Pulido
Journal:  Cell Death Differ       Date:  2006-12-22       Impact factor: 15.828

2.  Alternate molecular genetic pathways in ovarian carcinomas of common histological types.

Authors:  Julia Willner; Kaitlyn Wurz; Kimberly H Allison; Vijaya Galic; Rochelle L Garcia; Barbara A Goff; Elizabeth M Swisher
Journal:  Hum Pathol       Date:  2007-01-29       Impact factor: 3.466

3.  A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes.

Authors:  Isabel Rodríguez-Escudero; María D Oliver; Amparo Andrés-Pons; María Molina; Víctor J Cid; Rafael Pulido
Journal:  Hum Mol Genet       Date:  2011-08-09       Impact factor: 6.150

Review 4.  PTEN and myotubularin: novel phosphoinositide phosphatases.

Authors:  T Maehama; G S Taylor; J E Dixon
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

5.  PTEN/MMAC1 mutations in endometrial cancers.

Authors:  J I Risinger; A K Hayes; A Berchuck; J C Barrett
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

6.  Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay.

Authors:  S Y Han; H Kato; S Kato; T Suzuki; H Shibata; S Ishii; K Shiiba; S Matsuno; R Kanamaru; C Ishioka
Journal:  Cancer Res       Date:  2000-06-15       Impact factor: 12.701

7.  Jalview Version 2--a multiple sequence alignment editor and analysis workbench.

Authors:  Andrew M Waterhouse; James B Procter; David M A Martin; Michèle Clamp; Geoffrey J Barton
Journal:  Bioinformatics       Date:  2009-01-16       Impact factor: 6.937

Review 8.  Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.

Authors:  Masaki Mandai; Ken Yamaguchi; Noriomi Matsumura; Tsukasa Baba; Ikuo Konishi
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

9.  UniProt Knowledgebase: a hub of integrated protein data.

Authors:  Michele Magrane
Journal:  Database (Oxford)       Date:  2011-03-29       Impact factor: 3.451

10.  CUPSAT: prediction of protein stability upon point mutations.

Authors:  Vijaya Parthiban; M Michael Gromiha; Dietmar Schomburg
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

View more
  11 in total

1.  MTV proteins unveil ER- and microtubule-associated compartments in the plant vacuolar trafficking pathway.

Authors:  María Otilia Delgadillo; Guillermo Ruano; Jan Zouhar; Michael Sauer; Jinbo Shen; Aleksandra Lazarova; Maite Sanmartín; Louis Tung Faat Lai; Cesi Deng; Pengwei Wang; Patrick J Hussey; José Juan Sánchez-Serrano; Liwen Jiang; Enrique Rojo
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-22       Impact factor: 11.205

2.  Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapy.

Authors:  Montserrat Estruch; Kristian Reckzeh; Camilla Vittori; Anders Centio; Mina Ali; Sophia Engelhard; Ling Zhao; Kyoung Jae Won; Paul Liu; Bo Torben Porse; Kim Theilgaard-Mönch
Journal:  Leukemia       Date:  2020-12-09       Impact factor: 11.528

3.  Dynamics and structural stability effects of germline PTEN mutations associated with cancer versus autism phenotypes.

Authors:  Iris Nira Smith; Stetson Thacker; Ritika Jaini; Charis Eng
Journal:  J Biomol Struct Dyn       Date:  2018-05-14

4.  Conformational Dynamics and Allosteric Regulation Landscapes of Germline PTEN Mutations Associated with Autism Compared to Those Associated with Cancer.

Authors:  Iris Nira Smith; Stetson Thacker; Marilyn Seyfi; Feixiong Cheng; Charis Eng
Journal:  Am J Hum Genet       Date:  2019-04-18       Impact factor: 11.025

5.  Mouse model and human patient data reveal critical roles for Pten and p53 in suppressing POLE mutant tumor development.

Authors:  Vivian S Park; Meijuan J S Sun; Wesley D Frey; Leonard G Williams; Karl P Hodel; Juliet D Strauss; Sydney J Wellens; James G Jackson; Zachary F Pursell
Journal:  NAR Cancer       Date:  2022-03-03

Review 6.  Mitochondrial Superoxide Dismutase: What the Established, the Intriguing, and the Novel Reveal About a Key Cellular Redox Switch.

Authors:  Flavio R Palma; Chenxia He; Jeanne M Danes; Veronica Paviani; Diego R Coelho; Benjamin N Gantner; Marcelo G Bonini
Journal:  Antioxid Redox Signal       Date:  2020-04-01       Impact factor: 8.401

Review 7.  PTEN and Gynecological Cancers.

Authors:  Camilla Nero; Francesca Ciccarone; Antonella Pietragalla; Giovanni Scambia
Journal:  Cancers (Basel)       Date:  2019-09-28       Impact factor: 6.639

8.  DORGE: Discovery of Oncogenes and tumoR suppressor genes using Genetic and Epigenetic features.

Authors:  Jie Lyu; Jingyi Jessica Li; Jianzhong Su; Fanglue Peng; Yiling Elaine Chen; Xinzhou Ge; Wei Li
Journal:  Sci Adv       Date:  2020-11-11       Impact factor: 14.136

9.  Loss of phosphatase activity in PTEN (phosphatase and tensin homolog deleted on chromosome ten) results in endometrial carcinoma in humans: An in-silico study.

Authors:  Sunil Kanti Mondal; Madhab Kumar Sen
Journal:  Heliyon       Date:  2020-01-06

10.  The Novel Phosphatase Domain Mutations Q171R and Y65S Switch PTEN from Tumor Suppressor to Oncogene.

Authors:  Jose Antonio Ma G Garrido; Krizelle Mae M Alcantara; Joshua Miguel C Danac; Fidel Emmanuel C Serrano; Eva Maria Cutiongco-de la Paz; Reynaldo L Garcia
Journal:  Cells       Date:  2021-12-05       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.